A study examining the real-world effectiveness of the Pfizer-BioNTech vaccine in the UK showed it generated a strong immune response in older people. AFP
A study examining the real-world effectiveness of the Pfizer-BioNTech vaccine in the UK showed it generated a strong immune response in older people. AFP